
|Articles|September 17, 2021
AJMC® in the Press, September 17, 2021
Author(s)AJMC Staff
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Advertisement
A daily news roundup by
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Sibeprenlimab for Immunoglobulin A Nephropathy
2
Ocrelizumab Leads to Lower Hospitalization Rates Compared to Rituximab in MS
3
Faricimab Brought Early Control of Some Symptoms in AMD
4
Zanubrutinib Shows Similar Efficacy but Better Safety Than VEN–I in Frontline CLL
5













































